USD 15.97
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 63.23 Billion JPY | -29.68% |
2023 | 89.92 Billion JPY | -19.57% |
2022 | 111.79 Billion JPY | 46.7% |
2021 | 76.2 Billion JPY | 32.36% |
2020 | 57.57 Billion JPY | -7.06% |
2019 | 61.95 Billion JPY | -14.49% |
2018 | 72.45 Billion JPY | -9.08% |
2017 | 79.68 Billion JPY | -2.12% |
2016 | 81.41 Billion JPY | 1.26% |
2015 | 80.39 Billion JPY | -2.78% |
2014 | 82.69 Billion JPY | 8.07% |
2013 | 76.51 Billion JPY | 13.53% |
2012 | 67.4 Billion JPY | 9.73% |
2011 | 61.42 Billion JPY | 10.39% |
2010 | 55.64 Billion JPY | 9.14% |
2009 | 50.98 Billion JPY | -0.51% |
2008 | 51.24 Billion JPY | 1.97% |
2007 | 50.25 Billion JPY | -6.03% |
2006 | 53.47 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | 57.26 Billion JPY | -36.32% |
2024 Q1 | 14.97 Billion JPY | -11.35% |
2024 Q2 | 16.52 Billion JPY | 10.33% |
2024 Q3 | 17.06 Billion JPY | 3.26% |
2024 Q4 | 14.52 Billion JPY | -14.89% |
2023 Q3 | 22.79 Billion JPY | -10.05% |
2023 FY | 89.92 Billion JPY | -19.57% |
2023 Q4 | 16.89 Billion JPY | -25.88% |
2023 Q1 | 24.89 Billion JPY | -22.17% |
2023 Q2 | 25.34 Billion JPY | 1.78% |
2022 Q1 | 25.35 Billion JPY | 18.07% |
2022 Q2 | 29.55 Billion JPY | 16.54% |
2022 FY | 111.79 Billion JPY | 46.7% |
2022 Q3 | 24.9 Billion JPY | -15.72% |
2022 Q4 | 31.98 Billion JPY | 28.44% |
2021 Q1 | 12.54 Billion JPY | -5.58% |
2021 Q4 | 21.47 Billion JPY | -6.73% |
2021 Q3 | 23.02 Billion JPY | 20.17% |
2021 FY | 76.2 Billion JPY | 32.36% |
2021 Q2 | 19.16 Billion JPY | 52.68% |
2020 FY | 57.57 Billion JPY | -7.06% |
2020 Q1 | 14.76 Billion JPY | -0.75% |
2020 Q2 | 14.74 Billion JPY | -0.1% |
2020 Q3 | 14.77 Billion JPY | 0.17% |
2020 Q4 | 13.29 Billion JPY | -10.04% |
2019 Q4 | 14.87 Billion JPY | -5.2% |
2019 Q3 | 15.69 Billion JPY | 1.81% |
2019 FY | 61.95 Billion JPY | -14.49% |
2019 Q1 | 15.97 Billion JPY | 10.73% |
2019 Q2 | 15.41 Billion JPY | -3.52% |
2018 Q2 | 19.81 Billion JPY | -4.98% |
2018 Q4 | 14.42 Billion JPY | -16.87% |
2018 Q1 | 20.85 Billion JPY | 9.05% |
2018 FY | 72.45 Billion JPY | -9.08% |
2018 Q3 | 17.35 Billion JPY | -12.42% |
2017 Q2 | 19.89 Billion JPY | -3.17% |
2017 FY | 79.68 Billion JPY | -2.12% |
2017 Q4 | 19.12 Billion JPY | -4.91% |
2017 Q3 | 20.11 Billion JPY | 1.07% |
2017 Q1 | 20.55 Billion JPY | 6.28% |
2016 Q2 | 21.18 Billion JPY | 3.63% |
2016 Q1 | 20.44 Billion JPY | 6.29% |
2016 Q4 | 19.33 Billion JPY | -5.42% |
2016 Q3 | 20.44 Billion JPY | -3.5% |
2016 FY | 81.41 Billion JPY | 1.26% |
2015 Q1 | 20.28 Billion JPY | 0.6% |
2015 FY | 80.39 Billion JPY | -2.78% |
2015 Q4 | 19.23 Billion JPY | -5.88% |
2015 Q3 | 20.43 Billion JPY | -0.01% |
2015 Q2 | 20.43 Billion JPY | 0.73% |
2014 Q4 | 20.16 Billion JPY | -4.27% |
2014 FY | 82.69 Billion JPY | 8.07% |
2014 Q1 | 20.3 Billion JPY | 9.72% |
2014 Q2 | 21.14 Billion JPY | 4.13% |
2014 Q3 | 21.06 Billion JPY | -0.38% |
2013 Q2 | 18.67 Billion JPY | -6.26% |
2013 Q4 | 18.51 Billion JPY | -4.69% |
2013 FY | 76.51 Billion JPY | 13.53% |
2013 Q1 | 19.91 Billion JPY | 7.06% |
2013 Q3 | 19.42 Billion JPY | 4.01% |
2012 FY | 67.4 Billion JPY | 9.73% |
2012 Q2 | 15.79 Billion JPY | -3.09% |
2012 Q3 | 16.7 Billion JPY | 5.74% |
2012 Q4 | 18.6 Billion JPY | 11.39% |
2012 Q1 | 16.29 Billion JPY | 8.67% |
2011 Q4 | 14.99 Billion JPY | -7.36% |
2011 FY | 61.42 Billion JPY | 10.39% |
2011 Q1 | 15.4 Billion JPY | 20.5% |
2011 Q3 | 16.18 Billion JPY | 9.13% |
2011 Q2 | 14.83 Billion JPY | -3.69% |
2010 Q3 | 14.42 Billion JPY | 1.37% |
2010 Q1 | 14.21 Billion JPY | 17.44% |
2010 Q4 | 12.78 Billion JPY | -11.37% |
2010 FY | 55.64 Billion JPY | 9.14% |
2010 Q2 | 14.22 Billion JPY | 0.11% |
2009 Q4 | 12.1 Billion JPY | -8.55% |
2009 Q3 | 13.23 Billion JPY | 0.24% |
2009 Q2 | 13.2 Billion JPY | 0.0% |
2009 FY | 50.98 Billion JPY | -0.51% |
2008 FY | 51.24 Billion JPY | 1.97% |
2007 FY | 50.25 Billion JPY | -6.03% |
2006 FY | 53.47 Billion JPY | 0.0% |
2005 Q4 | - JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Bio Medica Corporation | -193 Thousand USD | 32764348.705% |
Arrayit Corporation | 2.57 Million USD | -2455572.843% |
Atlantic International Corp. | -154.23 Thousand USD | 40999490.536% |
Biocept, Inc. | -2.58 Million USD | 2449170.488% |
Bioqual, Inc. | 7.42 Million USD | -851076.039% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 276 Thousand USD | -22911131.884% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | -838.212% |
HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -3524535.943% |
iMD Companies, Inc. | -23.63 Thousand USD | 267525589.698% |
IDenta Corp. | 662.97 Thousand USD | -9537967.046% |
Interpace Biosciences, Inc. | 23.04 Million USD | -274321.733% |
Integrative Health Technologies, Inc. | 77.57 Thousand USD | -81518766.587% |
InVitro International | 635.98 Thousand USD | -9942744.564% |
Lumos Diagnostics Holdings Limited | 6.56 Million USD | -963407.542% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 1.09 Million USD | -5787026.013% |
NovelStem International Corp. | 12 Thousand USD | -526958233.333% |
Optigenex Inc. | -102.96 Thousand USD | 61413576.293% |
PharmChem, Inc. | 3.9 Million USD | -1619492.99% |
Proteome Sciences plc | 2.09 Million USD | -3015929.049% |
Response Genetics, Inc | 3.94 Million USD | -1604034.957% |
Rennova Health, Inc. | 6.26 Million USD | -1008714.101% |
RushNet, Inc. | 1.1 Million USD | -5724518.985% |
ScreenPro Security Inc. | 856.57 Thousand USD | -7382216.064% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | -403.74 Thousand USD | 15662135.879% |
Todos Medical Ltd. | 4.31 Million USD | -1467069.374% |